Prevalence and predictors of Toxoplasma seropositivity in women with and at risk for human immunodeficiency virus infection

被引：38

作者：

Falusi, O

French, AL

Seaberg, EC

Tien, PC

Watts, DH

Minkoff, H

Piessens, E

Kovacs, A

Anastos, K

Cohen, MH

机构：

[1] Cook Cty Hosp, Div Infect Dis, Chicago, IL 60612 USA

[2] Rush Med Coll, Chicago, IL 60612 USA

[3] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA

[4] NICHHD, Bethesda, MD 20892 USA

[5] Univ Calif San Francisco, San Francisco, CA 94143 USA

[6] Univ So Calif, Keck Sch Med, Los Angeles, CA USA

[7] Maimonides Hosp, Brooklyn, NY 11219 USA

[8] Montefiore Med Ctr, Lincoln Med & Mental Hlth Ctr, Bronx, NY 10467 USA

[9] Georgetown Univ Hosp, Washington, DC 20007 USA

来源：

CLINICAL INFECTIOUS DISEASES | 2002年 / 35卷 / 11期

关键词：

D O I：

10.1086/344462

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 [免疫学];

摘要：

We assessed the prevalence and predictors of latent Toxoplasma infection in a large group of human immunodeficiency virus (HIV)-infected and HIV-uninfected at-risk US women. The prevalence of latent Toxoplasma infection was 15% (380 of 2525 persons) and did not differ by HIV infection status. HIV-infected women aged greater than or equal to50 years and those born outside of the United States were more likely to have latent Toxoplasma infection, with prevalences of 32% and 41%, respectively.

引用

页码：1414 / 1417

页数：4

共 13 条

[1]

The Women's Interagency HIV Study [J].